OngoingEUCTR 2008-001015-38
Central cannabinoid (CB1) receptor antagonist rimonabant for schizophrenia
This study is ongoing in Germany. It is testing central cannabinoid (CB1) receptor antagonist rimonabant for schizophrenia.
SchizophreniaOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
OngoingEUCTR 2021-004790-31
Safety study of JNJ-55308942 in depression in bipolarity
This study is ongoing in Spain, in Poland, and in View results. It is testing JNJ-55308942 for depression in bipolarity.
Bipolarity, DepressionOther
CompletedNCT04655287
A Register Study of Effects Following Local Variation in Rates of Involuntary Care
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Enrolling By InvitationNCT07131137
A Remote Life Balance Training Program for People With Schizophrenia
This study is enrolling by invitation. It focuses on schizophrenia and currently lists participation information in Turkey.
SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT00566449
A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder.
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 18 Years to 64 Years
CompletedNCT01592110
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in people with Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
SchizophreniaOtherOver 18 Years
CompletedNCT00845026
A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
This study is completed. It focuses on schizophrenia and currently lists study information in Germany, Mexico, Russian Federation, and the United States.
SchizophreniaOtherFrom 18 Years to 65 Years
CompletedNCT01051531
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to people with Schizophrenia
This study is completed in Australia, in New Zealand, in China, .... It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 50 Years
CompletedNCT05721235
A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
This study is completed. It focuses on ADHD and currently lists study information in the United States.
ADHDOtherFrom 4 Years to 5 Years
UnknownNCT05526235
A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities
This study has public registry information. It focuses on depression and currently lists study information in Spain.
Depression, AnxietyBehavioralFrom 18 Years to 65 Years
CompletedNCT00885716
A Shared Decision Making Training for Inpatients With Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Germany.
SchizophreniaOtherFrom 18 Years to 60 Years
CompletedNCT01909011
A Single Blind Study of Cranial Electrical Stimulation in Bipolarity II
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
BipolarityOtherFrom 18 Years to 85 Years